Domestic purchasing channels and price guide for pemetinib/pemetinib

Pemigatinib(Pemigatinib), as an advanced treatment drug for cholangiocarcinoma with specific genetic markers, has brought new hope to many patients. This drug is mainly targeted at adult patients whose cancer has metastasized or cannot be surgically removed, and has shown its unique therapeutic potential when other drug treatments are ineffective. However, for many patients and their families, how to purchase pemetinib in China and the price of the drug are their biggest concerns.

Currently, the original drug of pemetinib has been launched in China, but it has not yet been included in the medical insurance catalog. Therefore, patients need to purchase it in full at their own expense. Depending on market conditions, the price of each box of pemetinib may be around RMB 50,000, which is undoubtedly a heavy burden for many patients. Given that drug prices and supply may vary by region and sales channel, patients or family members are advised to consult their local tertiary hospitals and large pharmacies before purchasing to obtain the most accurate price information and purchasing advice.

In addition, some patients may consider purchasing pemetinib or its generic versions from overseas markets. However, it should be noted that there are certain risks and uncertainties in drug prices, quality and transportation in overseas markets. Therefore, when choosing to purchase drugs overseas, be sure to choose a formal and reputable drug sales platform, and purchase and use them under the guidance of a doctor.

In general, although pemetinib provides a new treatment option for patients with cholangiocarcinoma, its high price and limited purchase channels are still the main challenges faced by patients. It is hoped that as time goes by and policies are adjusted, more patients will have access to this advanced drug treatment.